作者: Joseph Glenn , Wenyu Zhu , James D. Rodgers
DOI:
关键词:
摘要: The present invention provides heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines of Formula I: wherein X, Y, Z, L, A, R5, n, m, r are defined above, as well their compositions methods use, that modulate the activity Janus kinases (JAKs) useful in treatment diseases related to JAKs including, for example, inflammatory disorders, autoimmune cancer, other diseases.